Literature DB >> 12354844

Multidisciplinary management of hepatocellular carcinoma.

William S Rilling1, Alain Drooz.   

Abstract

Hepatocellular carcinoma is a challenging disease to treat because of its association with cirrhosis, variable biologic behavior, and variable morphology and because of the variations in local expertise and resources available. The expertise of multiple specialties is required for optimal treatment, which must be individualized. Multidisciplinary and multimodality approaches can be successful for converting patients with unresectable disease into surgical candidates and can stabilize disease as patients await liver transplantation. Regional and local ablation treatment strategies provide effective palliation and possibly prolong survival in nonsurgical candidates, with novel combinations of therapies showing promising results. Interventional radiologists can and should play a lead role in the multidisciplinary management of this disease and in the development of future treatment strategies.

Entities:  

Mesh:

Year:  2002        PMID: 12354844     DOI: 10.1016/s1051-0443(07)61794-1

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  7 in total

1.  Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

Authors:  Ihab R Kamel; Eleni Liapi; Diane K Reyes; Marianna Zahurak; David A Bluemke; Jean-François H Geschwind
Journal:  Radiology       Date:  2009-02       Impact factor: 11.105

Review 2.  Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults.

Authors:  Christopher D Woodrell; Lissi Hansen; Thomas D Schiano; Nathan E Goldstein
Journal:  Clin Ther       Date:  2018-03-20       Impact factor: 3.393

3.  Determinants and outcomes of adherence to recommendations from a multidisciplinary tumour conference for hepatocellular carcinoma.

Authors:  Laurie Gashin; Elliot Tapper; Atinuke Babalola; Kuan-Chi Lai; Rebecca Miksad; Raza Malik; Eric Cohen
Journal:  HPB (Oxford)       Date:  2014-05-28       Impact factor: 3.647

4.  Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study.

Authors:  F Li; Z Guo; Y Zhang; H Wang; X Zhang; T Si; H Yu; L Qi
Journal:  Ir J Med Sci       Date:  2014-06-28       Impact factor: 1.568

5.  Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma.

Authors:  Zhen Zeng; Feng Shi; Lin Zhou; Min-Na Zhang; Yan Chen; Xiu-Juan Chang; Yin-Ying Lu; Wen-Lin Bai; Jian-Hui Qu; Chun-Ping Wang; Hong Wang; Min Lou; Fu-Sheng Wang; Ji-Yun Lv; Yong-Ping Yang
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

Review 6.  Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines.

Authors:  Ayman A Abdo; Mazen Hassanain; AbdulRahman AlJumah; Ashwaq Al Olayan; Faisal M Sanai; Hamad A Alsuhaibani; Huda Abdulkareem; Khalid Abdallah; Mohammad AlMuaikeel; Mohammad Al Saghier; Mohammad Babatin; Monther Kabbani; Shouki Bazarbashi; Peter Metrakos; Jordi Bruix
Journal:  Ann Saudi Med       Date:  2012 Mar-Apr       Impact factor: 1.526

Review 7.  Can team-based care improve patient satisfaction? A systematic review of randomized controlled trials.

Authors:  Jin Wen; Kevin A Schulman
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.